Document Detail


Estrogen receptor β selective agonists reduce invasiveness of triple‑negative breast cancer cells.
MedLine Citation:
PMID:  25420519     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Metastasis to bone is a frequent problem of advanced breast cancer. Particularly breast cancers, which do not express estrogen receptor α (ERα) and progesterone receptor (PR) and which have no overexpression of human epidermal growth factor receptor 2 (HER2), so‑called triple‑negative breast cancers (TNBCs), are considered as very aggressive and have a poor prognosis. Recently we have shown that breast cancer cell invasion was dramatically increased when co‑cultured with MG63 osteoblast‑like cells. Using this model we have now analyzed whether estrogen receptor β (ERβ) plays a role in TNBC cell invasion in vitro. ERα and ERβ protein expression was analyzed using western blot analysis. Invasion was quantified by assessment of TNBC cell migration rate through an artificial basement membrane in a modified Boyden chamber during co‑culture with MG63 osteoblast‑like cells. The effects of ERβ agonist treatment on CXC motif chemokine receptor 4 (CXCR4) protein expression during co‑culture with MG64 cells was quantified using western blot analysis. Proliferation was measured using alamarBlue assay. TNBC cell lines HCC1806 and HCC1937 showed no ERα but high ERβ protein expression. Cell invasion of HCC1806 and HCC1937 TNBC cells was significantly increased when co‑cultured with MG63 osteoblast‑like cells. Treatment with ERβ selective estrogen agonists liquiritigenin and ERB‑041 reduced the ability to invade a reconstituted basement membrane and to migrate in response to the cellular stimulus. During co‑culture CXCR4 protein expression of TNBC cell lines HCC1806 and HCC1937 was significantly increased. Treatment with liquiritigenin resulted in a significant decrease of CXCR4 protein expression. Both ERβ agonists showed no effect on TNBC cell proliferation. Our findings suggest that ERβ plays a major role in TNBC invasion. Bone‑directed invasion can be inhibited by ERβ agonists.
Authors:
Oliver Hinsche; Rainer Girgert; Günter Emons; Carsten Gründker
Related Documents :
2505719 - Identification of aggregation substances of enterococcus faecalis cells after induction...
20614479 - Interstitial cells of cajal, the maestro in health and disease.
2319489 - Effect of extracellular ions on motility and cell entry in toxoplasma gondii.
21483099 - Tyrosine phosphatases in the her2-directed motility of ovarian cancer cells: involvemen...
18090319 - The tropism of embryoid body cells for glioma cells.
18158109 - Time-lapse analysis of aggregate formation in an inducible pc12 cell model of huntingto...
19593789 - Profilin-1 overexpression restores adherens junctions in mda-mb-231 breast cancer cells...
9921639 - Isolation and collection of two populations of viable sperm cells from the pollen of pl...
10336989 - Expression of the insulin-like growth factor 1 receptor (igf-1r) in breast cancer cells...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-11-25
Journal Detail:
Title:  International journal of oncology     Volume:  -     ISSN:  1791-2423     ISO Abbreviation:  Int. J. Oncol.     Publication Date:  2014 Nov 
Date Detail:
Created Date:  2014-11-25     Completed Date:  -     Revised Date:  2014-11-26    
Medline Journal Info:
Nlm Unique ID:  9306042     Medline TA:  Int J Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mental, neurological, and substance use problems among refugees in primary health care: analysis of ...
Next Document:  ERG induces taxane resistance in castration-resistant prostate cancer.